1. Home
  2. INTS vs AWX Comparison

INTS vs AWX Comparison

Compare INTS & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • AWX
  • Stock Information
  • Founded
  • INTS 2012
  • AWX 1998
  • Country
  • INTS United States
  • AWX United States
  • Employees
  • INTS N/A
  • AWX N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • AWX Environmental Services
  • Sector
  • INTS Health Care
  • AWX Utilities
  • Exchange
  • INTS Nasdaq
  • AWX Nasdaq
  • Market Cap
  • INTS 9.4M
  • AWX 9.5M
  • IPO Year
  • INTS 2023
  • AWX 1998
  • Fundamental
  • Price
  • INTS $0.32
  • AWX $2.45
  • Analyst Decision
  • INTS Strong Buy
  • AWX
  • Analyst Count
  • INTS 3
  • AWX 0
  • Target Price
  • INTS $8.50
  • AWX N/A
  • AVG Volume (30 Days)
  • INTS 2.7M
  • AWX 18.7K
  • Earning Date
  • INTS 08-07-2025
  • AWX 08-07-2025
  • Dividend Yield
  • INTS N/A
  • AWX N/A
  • EPS Growth
  • INTS N/A
  • AWX N/A
  • EPS
  • INTS N/A
  • AWX 0.20
  • Revenue
  • INTS N/A
  • AWX $81,005,000.00
  • Revenue This Year
  • INTS N/A
  • AWX N/A
  • Revenue Next Year
  • INTS N/A
  • AWX N/A
  • P/E Ratio
  • INTS N/A
  • AWX $11.97
  • Revenue Growth
  • INTS N/A
  • AWX N/A
  • 52 Week Low
  • INTS $0.26
  • AWX $2.07
  • 52 Week High
  • INTS $5.10
  • AWX $3.99
  • Technical
  • Relative Strength Index (RSI)
  • INTS 37.08
  • AWX 48.16
  • Support Level
  • INTS $0.28
  • AWX $2.36
  • Resistance Level
  • INTS $0.32
  • AWX $2.49
  • Average True Range (ATR)
  • INTS 0.06
  • AWX 0.10
  • MACD
  • INTS 0.01
  • AWX 0.01
  • Stochastic Oscillator
  • INTS 7.43
  • AWX 71.43

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: